We are live on ! Find out more
BGA

Belmont Global Advisors Portfolio holdings

AUM $106M
1-Year Est. Return 2.89%
This Fund
S&P 500
This Quarter Est. Return
-6.75%
1 Year Est. Return
-2.89%
3 Year Est. Return
+81.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$104M
AUM Growth
+$5.86M
Cap. Flow
+$19.7M
Cap. Flow %
18.87%
Top 10 Hldgs %
68.04%
Holding
87
New
29
Increased
18
Reduced
11
Closed
23

Top Buys

Rank Stock Value
1
TCRT icon
Alaunos Therapeutics
TCRT
+$1.78M
2
MNDT
Mandiant, Inc. Common Stock
MNDT
+$970K
3
MFINL
Medallion Financial Corp 9.000% Notes due 2021
MFINL
+$754K
4
UAL icon
United Airlines
UAL
+$710K
5
PANW icon
Palo Alto Networks
PANW
+$695K

Top Sells

Rank Stock Value
1
PGEN icon
Precigen
PGEN
+$2.86M
2
FIZZ icon
National Beverage
FIZZ
+$2.81M
3
TVIX
VelocityShares Daily 2x VIX Short Term ETN
TVIX
+$1.38M
4
MCD icon
McDonald's
MCD
+$943K
5
NKE icon
Nike
NKE
+$922K

Sector Composition

Rank Sector Weight
1 Healthcare 23.21%
2 Technology 6.61%
3 Consumer Discretionary 4.27%
4 Industrials 4.23%
5 Financials 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$787B
$15.7M 15.08%
+75,000
New +$15.6M
TCRT icon
2
CALL
Alaunos Therapeutics
TCRT
$4.76M
$13.2M 12.68%
16,033
+5,500
+52% +$5.99M
PGEN icon
3
CALL
Precigen
PGEN
$1.9B
$11.7M 11.22%
479,275
+252,250
+111% +$7.16M
TCRT icon
4
Alaunos Therapeutics
TCRT
$4.76M
$9.98M 9.58%
12,120
+1,633
+16% +$1.78M
PGEN icon
5
Precigen
PGEN
$1.9B
$6.9M 6.63%
283,075
-100,698
-26% -$2.86M
ACAD icon
6
CALL
Acadia Pharmaceuticals
ACAD
$4.27B
$4.87M 4.67%
+150,000
New +$5.02M
TBT icon
7
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$292M
$3.17M 3.04%
+100,000
New +$3.56M
FRO icon
8
CALL
Frontline
FRO
$8.45B
$2.36M 2.27%
300,000
– –
VBTX
9
DELISTED
Veritex Holdings
VBTX
$1.51M 1.45%
94,229
– –
FBIO icon
10
Fortress Biotech
FBIO
$118M
$1.48M 1.42%
36,667
-4,000
-10% -$186K
SGYP
11
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1.46M 1.4%
385,000
-15,000
-4% -$50.8K
HD icon
12
Home Depot
HD
$330B
$1.28M 1.23%
10,050
-2,000
-17% -$264K
ACAD icon
13
Acadia Pharmaceuticals
ACAD
$4.27B
$1.23M 1.18%
38,000
+8,000
+27% +$268K
AMZN icon
14
Amazon
AMZN
$2.63T
$1.08M 1.04%
30,160
+10,000
+50% +$338K
PANW icon
15
Palo Alto Networks
PANW
$273B
$1.04M 1%
51,000
+30,000
+143% +$695K
BHK icon
16
BlackRock Core Bond Trust
BHK
$643M
$1.03M 0.99%
73,614
+40,250
+121% +$547K
MSFT icon
17
Microsoft
MSFT
$2.9T
$1.03M 0.99%
20,055
+7,500
+60% +$390K
MNDT
18
DELISTED
Mandiant, Inc. Common Stock
MNDT
$988K 0.95%
+60,000
New +$970K
LJPC
19
DELISTED
La Jolla Pharmaceutical Company
LJPC
$960K 0.92%
60,000
+10,000
+20% +$179K
ORLY icon
20
O'Reilly Automotive
ORLY
$71.7B
$952K 0.91%
52,680
-7,500
-12% -$133K
HALO icon
21
CALL
Halozyme
HALO
$9.23B
$949K 0.91%
110,000
+77,200
+235% +$762K
DY icon
22
Dycom Industries
DY
$13B
$898K 0.86%
10,000
-2,500
-20% -$189K
META icon
23
Meta Platforms (Facebook)
META
$1.59T
$880K 0.84%
7,700
-2,500
-25% -$288K
AWK icon
24
American Water Works
AWK
$26.1B
$846K 0.81%
10,015
-5,000
-33% -$372K
PDI icon
25
PIMCO Dynamic Income Fund
PDI
$7.49B
$815K 0.78%
29,572
-20,400
-41% -$551K
1
2 3 4

Similar funds

LOT
Lombard Odier Transatlantic Montreal, Quebec, Canada $105M AUM 10.28% 1-Year Est. Return
EC
Eachwin Capital New York $108M AUM 14.45% 1-Year Est. Return
SAMNY
Samsung Asset Management (New York) New York $109M AUM 14.34% 1-Year Est. Return
DCMM
DG Capital Management (Massachusetts) Boston, Massachusetts $102M AUM 29.14% 1-Year Est. Return
PCM
Panning Capital Management New York $97.5M AUM 302.5% 1-Year Est. Return
SVGI
Sapphire Ventures (GPE) I Palo Alto, California $115M AUM 11.63% 1-Year Est. Return
EDRM
Edmond de Rothschild (Monaco) Monaco $116M AUM
EDRAML
Edmond de Rothschild Asset Management (Luxembourg) Luxembourg $95.2M AUM 19.45% 1-Year Est. Return

Belmont Global Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Belmont Global Advisors held 87 positions worth $104M, up 6% from $98.3M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Belmont Global Advisors deployed $19.7M of net new capital in Q2 2016, opening 29 new positions and adding to 18 existing holdings. Its largest new stake was Mandiant, Inc. Common Stock: 60,000 shares worth $988K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Precigen, an estimated $2.86M trimmed.

  • Belmont Global Advisors's largest Q2 2016 buy was Mandiant, Inc. Common Stock: 60,000 shares worth $988K.
  • Belmont Global Advisors added most to Alaunos Therapeutics in Q2 2016, an estimated $1.78M increase.
  • Belmont Global Advisors's biggest Q2 2016 reduction was Precigen, cutting an estimated $2.86M.
  • Belmont Global Advisors fully exited VelocityShares Daily 2x VIX Short Term ETN in Q2 2016, selling an estimated $1.38M.
  • Belmont Global Advisors's ten largest holdings make up 68% of its $104M portfolio in Q2 2016.
  • Belmont Global Advisors opened 29 new positions and closed 23 in Q2 2016.
  • Belmont Global Advisors's portfolio value rose 6% quarter-over-quarter to $104M.

Based on Belmont Global Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.